A Naturally Occurring hPMS2 Mutation Can Confer a Dominant Negative Mutator Phenotype

Por Nicolaides, Nicholas C., Littman, Susan J., Modrich, Paul, Kinzler, Kenneth W., Vogelstein, Bert
Publicado em 1998

Recent Treatment Advances and Novel Therapies in Pancreas Cancer: A Review

Por Valsecchi, Matias E., Díaz-Cantón, Enrique, de la Vega, Máximo, Littman, Susan J.
Publicado em 2013

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

Por Valsecchi Matias E, Holdbrook Thomas, Leiby Benjamin E, Pequignot Edward, Littman Susan J, Yeo Charles J, Brody Jonathan R, Witkiewicz Agnieszka K
Publicado em 2012-03-01

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

Por Valsecchi, Matias E, Holdbrook, Thomas, Leiby, Benjamin E, Pequignot, Edward, Littman, Susan J, Yeo, Charles J, Brody, Jonathan R, Witkiewicz, Agnieszka K
Publicado em 2012

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

Por Monti, Daniel A., Mitchell, Edith, Bazzan, Anthony J., Littman, Susan, Zabrecky, George, Yeo, Charles J., Pillai, Madhaven V., Newberg, Andrew B., Deshmukh, Sandeep, Levine, Mark
Publicado em 2012